Medindia

X

US Food And Drug Administration Approves Lupinís Calcium Acetate Capsules

by Shirley Johanna on  October 27, 2015 at 11:07 AM Drug News   - G J E 4
Lupin Pharmaceuticals has launched calcium acetate capsules, used to treat hyperphosphatemia in end stage renal failure, in the United States after receiving approval from the Food and Drug Administration (FDA).
US Food And Drug Administration Approves Lupinís Calcium Acetate Capsules
US Food And Drug Administration Approves Lupinís Calcium Acetate Capsules
Advertisement

Lupin Pharmaceuticals Inc, a subsidiary of the company, has launched calcium acetate capsules having received final approval from the US health regulator, the company said in a statement.

‘Lupin has launched calcium acetate capsules having received final approval from the US health regulator.’
Advertisement
The Mumbai-based firm's product is the generic version of Fresenius Medical Care North America's PhosLo Gelcaps.

The drug is indicated for the control of hyperphosphatemia in end stage renal failure.

As per IMS sales data, PhosLo Gelcaps had annual US sales of $54.5 million.

Shares in Lupin, on October 26, ended 1.25 percent lower at Rs. 2,053.40 apiece on the BSE, whose benchmark Sensex index finished down 0.4 percent.

Source: PTI
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All